TY - JOUR
T1 - Haplotype analysis to determine the position of a mutation among closely linked DNA markers
AU - Ramsay, Michele
AU - Williamson, Robert
AU - Estivill, Xavier
AU - Wainwright, Brandon J.
AU - Ho, Meng Fatt
AU - Halford, Stephanie
AU - Kere, Juha
AU - Savilahti, Erkki
AU - De La Chapelle, Albert
AU - Schwartz, Marianne
AU - Schwartz, Martin
AU - Super, Maurice
AU - Farndon, Peter
AU - Harding, Carol
AU - Meredith, Linda
AU - Al-Jader, Layla
AU - Ferec, Claude
AU - Claustres, Mireille
AU - Casals, Teresa
AU - Nunes, Virginia
AU - Gasparini, Paolo
AU - Savoia, Anna
AU - Pignatti, Pier Franco
AU - Novelli, Gluseppe
AU - Bennarelli, Massimo
AU - Dallapiccola, Bruno
AU - Kalaydjieva, Luba
AU - Scambler, Peter J.
PY - 1993/7
Y1 - 1993/7
N2 - Positional cloning involves first finding linkage between an inherited phenotype (such as a disease) and a DNA marker, followed by the use of a variety of physical and genetic mapping techniques to move from linkage to mutation. If there is a founder effect within a population, crossovers are often rare between the mutation causing the phenotype and closely situated markers and increasing disequilibrium may be observed as the site of the mutation is approached. Standard coefficients of disequilibrium may, however, be insensitive to the relative position of close markers and the mutation, because they depend upon allele frequencies in the normal population compared to those of the founder chromosome. Using cystic fibrosis in European populations as a model system, alternative methods for determining the position of a mutation are discussed. These include haplotype parsimony and three-way interval likelihood analysis. Both methods predict the location of the major CF mutation accurately from a real set of more than 600 European CF chromosomes.
AB - Positional cloning involves first finding linkage between an inherited phenotype (such as a disease) and a DNA marker, followed by the use of a variety of physical and genetic mapping techniques to move from linkage to mutation. If there is a founder effect within a population, crossovers are often rare between the mutation causing the phenotype and closely situated markers and increasing disequilibrium may be observed as the site of the mutation is approached. Standard coefficients of disequilibrium may, however, be insensitive to the relative position of close markers and the mutation, because they depend upon allele frequencies in the normal population compared to those of the founder chromosome. Using cystic fibrosis in European populations as a model system, alternative methods for determining the position of a mutation are discussed. These include haplotype parsimony and three-way interval likelihood analysis. Both methods predict the location of the major CF mutation accurately from a real set of more than 600 European CF chromosomes.
UR - http://www.scopus.com/inward/record.url?scp=0027292096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027292096&partnerID=8YFLogxK
M3 - Article
C2 - 8364537
AN - SCOPUS:0027292096
SN - 0964-6906
VL - 2
SP - 1007
EP - 1014
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 7
ER -